The Effect of Allergen Immunotherapy on Exhaled Nitric Oxide in Adult Patients With Asthma and Allergic Rhinitis

Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C.17 enrolled

Overview

This study will evaluate whether exhaled nitric oxide levels are affected by allergen immunotherapy ("allergy shots"). The investigators' hypothesis is that successful allergen immunotherapy may be accompanied by decreased exhaled nitric oxide levels.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Allergic Asthma Allergic Rhinitis

Interventions

Allergen immunotherapyBIOLOGICAL

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Subjects over 18 years old with allergic asthma and/or allergic rhinitis who are beginning allergen desensitization Exclusion Criteria: * Smokers * Subjects of dimished capacity

Locations (1)

Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C.

Bryn Mawr, Pennsylvania, United States

Outcomes

Primary Outcomes

Effect of allergen immunotherapy on exhaled nitric oxide

Time frame: One year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.